NDC product
Hydrocodone Bitartrate and Ibuprofen
NDC 13107-004 · Aurolife Pharma, LLC
Key facts
| Product NDC | 13107-004 |
|---|---|
| Proprietary name | Hydrocodone Bitartrate and Ibuprofen |
| Nonproprietary name | Hydrocodone Bitartrate and Ibuprofen |
| Substances | HYDROCODONE BITARTRATE, IBUPROFEN |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Aurolife Pharma, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA204575 |
| DEA schedule | CII |
| Pharmacologic classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC], Opioid Agonists [MoA] |
| Marketing start | Jun 2, 2016 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: